CLINICAL_TRIALS
trial_result
· 2019-02-12
Clinical Trial Update: Tocilizumab for Patients With Giant Cell Arteritis [Phase 2]
Summary
Phase 2 trial evaluating tocilizumab for giant cell arteritis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Giant Cell Arteritis | Phase 2 | Status: COMPLETED | Results posted: 2019-02-12